2022. Laboratory and clinical analysis of the treatment with direct-acting antiviral drugs in patients with hepatitis C. Research, Society and Development. 11, 14 (Oct. 2022), e49111435756. DOI:https://doi.org/10.33448/rsd-v11i14.35756.